Therefore, we elucidated a novel mechanism for how MBNL1-AS1 regulated the phenotype of BC and targeting the MBNL1-AS1/ZFP36/CENPA axis might function as therapeutic targets for breast cancer patients. This evidence concerns the gene CENPA and breast carcinoma.